Stocktoria

Viridian Therapeutics, Inc.DE VRDN

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2014-06-18

Viridian Therapeutics, Inc.DE statistics & valuation

Market cap$1.8B
P / S24.9×
P / B2.4×
Net margin-483.6%
Return on equity-47.4%
FCF margin-390.8%
Return on capital-43.9%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-496.80% -662.30% -390.00% -938.60% -10544.30% -2680.20% -7329.20% -75711.50% -89387.10% -483.60% 2016201720182019202020212022202320242025
Gross margin (%)
2016201720182019202020212022202320242025
Operating margin (%)
-488.60% -662.80% -394.50% -941.00% -10512.40% -2690.80% -7579.20% -81035.00% -99018.20% -512.90% 2016201720182019202020212022202320242025
Return on equity (%)
-68.80% -63.70% -265.80% -92.20% -42.30% -32.90% -53.80% -40.20% -47.40% 2016201720182019202020212022202320242025
Shares outstanding
833744 22.6M 30.8M 2.3M 4.2M 23.9M 41.3M 54.0M 81.0M 101.8M 2016201720182019202020212022202320242025
Net debt ($)
-$37.4M -$22.6M $7.7M $0 $4.6M $20.2M $20.6M 2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
-69.80% -50.50% -49.40% -138.40% -84.40% -39.00% -29.80% -48.50% -36.40% -38.10% 2016201720182019202020212022202320242025
Free cash flow margin (%)
-431.60% -709.80% -325.40% -810.10% -2840.10% -1853.50% -5340.60% -58938.90% -77096.00% -390.80% 2016201720182019202020212022202320242025
Debt / equity (×)
0.26× 0.19× 0.49× 0.00× 0.01× 0.05× 0.03× 2016201720182019202020212022202320242025
EPS ($)
-$31.13 -$6.66 -$4.05 -$5.31 2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating margin-512.9%-99018.2%-81035.0%-7579.2%-2690.8%-10512.4%-941.0%-394.5%-662.8%-488.6%
Net margin-483.6%-89387.1%-75711.5%-7329.2%-2680.2%-10544.3%-938.6%-390.0%-662.3%-496.8%
FCF margin-390.8%-77096.0%-58938.9%-5340.6%-1853.5%-2840.1%-810.1%-325.4%-709.8%-431.6%
Return on assets-38.1%-36.4%-48.5%-29.8%-39.0%-84.4%-138.4%-49.4%-50.5%-69.8%
Return on equity-47.4%-40.2%-53.8%-32.9%-42.3%-92.2%-265.8%-63.7%-68.8%27.9%
Debt / equity—0.03×0.05×0.01×0.00×—0.49×0.19×0.26×—
Current ratio12.6515.4318.2612.9314.6812.142.929.7113.313.47

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.